CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sterner, J. M.
Right arrow Articles by Horowitz, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sterner, J. M.
Right arrow Articles by Horowitz, J. M.

Cell Growth & Differentiation, Vol 7, Issue 1 53-64, Copyright © 1996 by American Association of Cancer Research


ARTICLES

The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression

JM Sterner, Y Tao, SB Kennett, HG Kim and JM Horowitz
Department of Molecular Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.

We have shown previously that a novel cell cycle-regulated histone H1 kinase activity, retinoblastoma kinase (RbK), associates with and phosphorylates the amino terminus of the Rb protein in G2-M. We have shown also that the amino terminus of p107, a Rb-related protein, does not associate with a similar kinase in vitro or in vivo. Here, we report that a RbK-like kinase associates with the amino terminus of p130, another Rb-related protein, only marginally. Moreover, the association of RbK with Rb in vitro is shown to require a discrete portion of the Rb amino terminus, amino acids 89-202. This region has been shown previously to be subject to inactivating mutations in retinoblastoma and to be required for Rb-mediated growth suppression in vitro. Taken together, these data indicate that the formation of Rb-RbK complexes may play an important role in Rb-mediated growth suppression. We have mapped two in vitro sites of Rb phosphorylation by RbK to sites that are phosphorylated in vivo and are targets of cyclin-dependent kinase phosphorylation in vitro. As such, at least some sites of RbK phosphorylation overlap with those of other proline-directed serine and threonine kinases. Consistent with this latter observation, we report that the trans-activation domain of c-myc is phosphorylated specifically by RbK in vitro at a site (serine 62) that is phosphorylated in vivo during G2-M, cell-cycle phases in which RbK activity is maximal.


This article has been cited by other articles:


Home page
IOVSHome page
R. H. Barbosa, F. C. C. Aguiar, M. F. L. Silva, R. A. Costa, F. R. Vargas, E. Lucena, M. Carvalho de Souza, L. M. de Almeida, C. Bittar, P. Ashton Prolla, et al.
Screening of RB1 Alterations in Brazilian Patients With Retinoblastoma and Relatives With Retinoma: Phenotypic and Genotypic Associations
, May 7, 2013; 54(5): 3184 - 3194.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
E. Batsche, J. Desroches, S. Bilodeau, Y. Gauthier, and J. Drouin
Rb Enhances p160/SRC Coactivator-dependent Activity of Nuclear Receptors and Hormone Responsiveness
J. Biol. Chem., May 20, 2005; 280(20): 19746 - 19756.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. S. Moorefield, S. J. Fry, and J. M. Horowitz
Sp2 DNA Binding Activity and trans-Activation Are Negatively Regulated in Mammalian Cells
J. Biol. Chem., April 2, 2004; 279(14): 13911 - 13924.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. Doostzadeh-Cizeron, R. Evans, S. Yin, and D. W. Goodrich
Apoptosis Induced by the Nuclear Death Domain Protein p84N5 Is Inhibited by Association with Rb Protein
Mol. Biol. Cell, October 1, 1999; 10(10): 3251 - 3261.
[Abstract] [Full Text]


Home page
J. Virol.Home page
V. L. Zacny, J. Wilson, and J. S. Pagano
The Epstein-Barr Virus Immediate-Early Gene Product, BRLF1, Interacts with the Retinoblastoma Protein during the Viral Lytic Cycle
J. Virol., October 1, 1998; 72(10): 8043 - 8051.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M. Sterner, S. Dew-Knight, C. Musahl, S. Kornbluth, and J. M. Horowitz
Negative Regulation of DNA Replication by the Retinoblastoma Protein Is Mediated by Its Association with MCM7
Mol. Cell. Biol., May 1, 1998; 18(5): 2748 - 2757.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. A. Otterson, W.-d. Chen, A. B. Coxon, S. N. Khleif, and F. J. Kaye
Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function
PNAS, October 28, 1997; 94(22): 12036 - 12040.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
R. S. Cuevo, S. Garrett, and J. M. Horowitz
Detection and Functional Characterization of p180, a Novel Cell Cycle Regulated Yeast Transcription Factor That Binds Retinoblastoma Control Elements
J. Biol. Chem., February 7, 1997; 272(6): 3813 - 3822.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.